Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19) ; volume:18 ; number:1 ; day:25 ; month:6 ; year:2020 ; pages:1-9 ; date:12.2020
Journal of translational medicine ; 18, Heft 1 (25.6.2020), 1-9, 12.2020
- Creator
-
Kim, Jason
Zhang, Jenny
Cha, Yoonjeong
Kolitz, Sarah
Funt, Jason
Escalante Chong, Renan
Barrett, Scott
Kusko, Rebecca
Zeskind, Ben
Kaufman, Howard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-020-02430-9
- URN
-
urn:nbn:de:101:1-2020082119594250001198
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Jason
- Zhang, Jenny
- Cha, Yoonjeong
- Kolitz, Sarah
- Funt, Jason
- Escalante Chong, Renan
- Barrett, Scott
- Kusko, Rebecca
- Zeskind, Ben
- Kaufman, Howard
- SpringerLink (Online service)
Other Objects (12)
Pooled effector library screening in protoplasts rapidly identifies novel Avr genes
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Integrative bioinformatics identifies postnatal lead (Pb) exposure disrupts developmental cortical plasticity
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts
A protein interaction map identifies existing drugs targeting SARS-CoV-2
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics
Emerging therapeutics
Pooled effector library screening in protoplasts rapidly identifies novel Avr genes
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Integrative bioinformatics identifies postnatal lead (Pb) exposure disrupts developmental cortical plasticity
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts
A protein interaction map identifies existing drugs targeting SARS-CoV-2
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics
Emerging therapeutics
Pooled effector library screening in protoplasts rapidly identifies novel Avr genes
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Integrative bioinformatics identifies postnatal lead (Pb) exposure disrupts developmental cortical plasticity
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts
A protein interaction map identifies existing drugs targeting SARS-CoV-2
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics